未登录

A

Ankit Balhara

university of washington

H指数:9

被引数:254

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rosuvastatin PBPK Modeling: Incorporating Liver Concentrations and Effects of Ethnicity, Genetic Polymorphisms, Lactone Formation, DDI and Pregnancy

罗苏伐他汀PBPK建模：整合肝脏浓度及种族、基因多态性、内酯形成、药物相互作用和妊娠的影响

cpt pharmacometrics systems pharmacology

IF0

2025-08-250

OAAI

Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-01-082

OAAI

Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor Approach

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-12-184

PRE

A Tribute to Professor Saranjit Singh-A Critical Thinker, Innovator, Mentor, and Educator

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2022-05-010

PRE

Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling

PHARMACEUTICAL RESEARCH

IF4.3

2022-03-172

PRE

Stress degradation study on entrectinib and characterization of its degradation products using HRMS and NMR

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2022-01-0112

PRE

PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid

PHARMACEUTICAL RESEARCH

IF4.3

2021-09-137

PRE

Exploration of inhibition potential of isoniazid and its metabolites towards CYP2E1 in human liver microsomes through LC-MS/MS analysis

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-09-014

PREAI

Comparative Proteomics Analysis of the Post-Mitochondrial Fraction (S9 Fraction) of Human Lens-Free Whole Eye and Liver

IF4.2

2021-05-140

PRE

Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-05-0115

PREAI

Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-04-014

PREAI

Insights into the degradation chemistry of tazarotene, a third generation acetylenic retinoid: LC-HRMS (Orbitrap), LC-MSn and NMR characterization of its degradation products, and prediction of their physicochemical and ADMET properties

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-07-019

PREAI

In vitro evaluation of reactive nature of E- and Z-guggulsterones and their metabolites in human liver microsomes using UHPLC-Orbitrap mass spectrometer

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-07-014

PREAI

Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-01-018

PREAI

A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation

SCIENTIFIC REPORTS

IF3.9

2019-07-0444

OAAI